Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma.

Thirasastr, Prapassorn; Lin, Heather; Amini, Behrang; Wang, Wei-Lien; Cloutier, Jeffrey M; Nassif, Elise F; Keung, Emily Z; Roland, Christina L; Feig, Barry; Araujo, Dejka; Benjamin, Robert S; Conley, Anthony P; Livingston, John A; Ludwig, Joseph; Patel, Shreyaskumar; Ratan, Ravin; Ravi, Vinod; Zarzour, Maria Alejandra; Zhou, Xiao; Somaiah, Neeta

Thirasastr, Prapassorn; Lin, Heather; Amini, Behrang; Wang, Wei-Lien; Cloutier, Jeffrey M; Nassif, Elise F; Keung, Emily Z; Roland, Christina L; Feig, Barry; Araujo, Dejka; Benjamin, Robert S; Conley, Anthony P; Livingston, John A; Ludwig, Joseph; Patel, Shreyaskumar; Ratan, Ravin; Ravi, Vinod; Zarzour, Maria Alejandra; Zhou, Xiao; Somaiah, Neeta.

Affiliation

Thirasastr P; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Lin H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Amini B; Department of Musculoskeletal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wang WL; Department of Pathology, Division of Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cloutier JM; Department of Pathology, Division of Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nassif EF; Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Keung EZ; Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Roland CL; Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Feig B; Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Araujo D; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Benjamin RS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Livingston JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ludwig J; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Patel S; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ratan R; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ravi V; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Zarzour MA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Zhou X; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Somaiah N; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Cancer Med ; 12(4): 4282-4293, 2023 02.

Article de En | MEDLINE | ID: mdl-36151848

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Gemcitabine / Liposarcome Limites: Adult / Aged / Aged80 / Humans / Middle aged Langue: En Journal: Cancer Med Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google